AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
≤2.5 20 24 20 24 O
× 25 26 25 26 I-upper_bound
institutional 27 40 27 40 I-upper_bound
upper 41 46 41 46 I-upper_bound
limit 47 52 47 52 I-upper_bound
of 53 55 53 55 I-upper_bound
normal 56 62 56 62 I-upper_bound
or 63 65 63 65 O
5 66 67 66 67 B-upper_bound
X 68 69 68 69 I-upper_bound
ULN 70 73 70 73 I-upper_bound

ECOG 0 4 74 78 B-clinical_variable
performance 5 16 79 90 I-clinical_variable
status 17 23 91 97 I-clinical_variable
≤2 24 26 98 100 O
( 27 28 101 102 O
see 29 32 103 106 O
Appendix 33 41 107 115 O
A 42 43 116 117 O
) 43 44 117 118 O

History 0 7 119 126 O
of 8 10 127 129 O
or 11 13 130 132 O
current 14 21 133 140 O
relevant 22 30 141 149 O
CNS 31 34 150 153 B-chronic_disease
pathology 35 44 154 163 I-chronic_disease
such 45 49 164 168 O
as 50 52 169 171 O
epilepsy 53 61 172 180 B-chronic_disease
, 61 62 180 181 O
seizure 63 70 182 189 B-chronic_disease
, 70 71 189 190 O
paresis 72 79 191 198 B-chronic_disease
, 79 80 198 199 O
aphasia 80 87 199 206 B-chronic_disease
, 87 88 206 207 O
apoplexia 89 98 208 217 B-chronic_disease
, 98 99 217 218 O
severe 100 106 219 225 B-chronic_disease
brain 107 112 226 231 I-chronic_disease
injuries 113 121 232 240 I-chronic_disease
, 121 122 240 241 O
cerebellar 123 133 242 252 B-chronic_disease
disease 134 141 253 260 I-chronic_disease
, 141 142 260 261 O
organic 143 150 262 269 B-chronic_disease
brain 151 156 270 275 I-chronic_disease
syndrome 157 165 276 284 I-chronic_disease
, 165 166 284 285 O
psychosis 167 176 286 295 B-chronic_disease

Marginal 0 8 296 304 B-cancer
zone 9 13 305 309 I-cancer
lymphoma 14 22 310 318 I-cancer
( 23 24 319 320 O
extranodal 24 34 320 330 B-cancer
, 34 35 330 331 O
nodal 36 41 332 337 O
, 41 42 337 338 O
or 43 45 339 341 O
splenic 46 53 342 349 B-cancer
) 53 54 349 350 O

Measurable 0 10 351 361 O
disease 11 18 362 369 O
that 19 23 370 374 O
has 24 27 375 378 O
not 28 31 379 382 O
been 32 36 383 387 O
previously 37 47 388 398 O
irradiated 48 58 399 409 O
on 59 61 410 412 O
PET 62 65 413 416 O
- 65 66 416 417 O
CT 66 68 417 419 O
of 69 71 420 422 O
at 72 74 423 425 O
least 75 80 426 431 O
1.5 81 84 432 435 B-lower_bound
cm 84 86 435 437 I-lower_bound

Participants 0 12 438 450 O
with 13 17 451 455 O
known 18 23 456 461 O
brain 24 29 462 467 B-cancer
metastases 30 40 468 478 I-cancer
should 41 47 479 485 O
be 48 50 486 488 O
excluded 51 59 489 497 O
from 60 64 498 502 O
this 65 69 503 507 O
clinical 70 78 508 516 O
trial 79 84 517 522 O
because 85 92 523 530 O
of 93 95 531 533 O
their 96 101 534 539 O
poor 102 106 540 544 O
prognosis 107 116 545 554 O
and 117 120 555 558 O
because 121 128 559 566 O
they 129 133 567 571 O
often 134 139 572 577 O
develop 140 147 578 585 O
progressive 148 159 586 597 O
neurologic 160 170 598 608 B-chronic_disease
dysfunction 171 182 609 620 I-chronic_disease
that 183 187 621 625 O
would 188 193 626 631 O
confound 194 202 632 640 O
the 203 206 641 644 O
evaluation 207 217 645 655 O
of 218 220 656 658 O
neurologic 221 231 659 669 O
and 232 235 670 673 O
other 236 241 674 679 O
adverse 242 249 680 687 O
events 250 256 688 694 O

Patients 0 8 695 703 O
with 9 13 704 708 O
splenic 14 21 709 716 B-cancer
MZL 22 25 717 720 I-cancer
must 26 30 721 725 O
have 31 35 726 730 O
prior 36 41 731 736 B-treatment
splenectomy 42 53 737 748 I-treatment

Pregnant 0 8 749 757 B-pregnancy

Prior 0 5 758 763 B-treatment
allogeneic 6 16 764 774 I-treatment
transplant 17 27 775 785 I-treatment

Prior 0 5 786 791 O
history 6 13 792 799 O
of 14 16 800 802 O
another 17 24 803 810 O
malignancy 25 35 811 821 B-cancer
( 36 37 822 823 O
except 37 43 823 829 O
for 44 47 830 833 O
non 48 51 834 837 B-cancer
- 51 52 837 838 I-cancer
melanoma 52 60 838 846 I-cancer
skin 61 65 847 851 I-cancer
cancer 66 72 852 858 I-cancer
, 72 73 858 859 O
in 74 76 860 862 B-cancer
situ 77 81 863 867 I-cancer
cervical 82 90 868 876 I-cancer
or 91 93 877 879 I-cancer
breast 94 100 880 886 I-cancer
cancer 101 107 887 893 I-cancer
, 107 108 893 894 O
or 109 111 895 897 O
localized 112 121 898 907 O
prostate 122 130 908 916 B-cancer
cancer 131 137 917 923 I-cancer
) 137 138 923 924 O
unless 139 145 925 931 O
disease 146 153 932 939 O
free 154 158 940 944 O
for 159 162 945 948 O
at 163 165 949 951 O
least 166 171 952 957 O
one 172 175 958 961 B-lower_bound
year 176 180 962 966 I-lower_bound
and 181 184 967 970 O
felt 185 189 971 975 O
at 190 192 976 978 O
low 193 196 979 982 O
risk 197 201 983 987 O
of 202 204 988 990 O
relapse 205 212 991 998 O
by 213 215 999 1001 O
treating 216 224 1002 1010 O
physician 225 234 1011 1020 O

Subjects 0 8 1021 1029 O
actively 9 17 1030 1038 O
progressing 18 29 1039 1050 O
within 30 36 1051 1057 O
that 37 41 1058 1062 O
window 42 48 1063 1069 O
who 49 52 1070 1073 O
have 53 57 1074 1078 O
recovered 58 67 1079 1088 O
from 68 72 1089 1093 O
toxicities 73 83 1094 1104 O
of 84 86 1105 1107 O
prior 87 92 1108 1113 O
therapy 93 100 1114 1121 B-treatment
are 101 104 1122 1125 O
also 105 109 1126 1130 O
eligible 110 118 1131 1139 O

Subjects 0 8 1140 1148 O
must 9 13 1149 1153 O
have 14 18 1154 1158 O
histologically 19 33 1159 1173 O
determined 34 44 1174 1184 O
B 45 46 1185 1186 B-cancer
cell 47 51 1187 1191 I-cancer
NHL 52 55 1192 1195 I-cancer
that 56 60 1196 1200 O
is 61 63 1201 1203 O
relapsed 64 72 1204 1212 O
or 73 75 1213 1215 O
primary 76 83 1216 1223 O
refractory 84 94 1224 1234 O
after 95 100 1235 1240 O
initial 101 108 1241 1248 O
therapy 109 116 1249 1256 B-treatment

Subjects 0 8 1257 1265 O
who 9 12 1266 1269 O
respond 13 20 1270 1277 O
to 21 23 1278 1280 O
initial 24 31 1281 1288 B-treatment
therapy 32 39 1289 1296 I-treatment
for 40 43 1297 1300 O
greater 44 51 1301 1308 O
than 52 56 1309 1313 O
one 57 60 1314 1317 B-lower_bound
year 61 65 1318 1322 I-lower_bound
must 66 70 1323 1327 O
have 71 75 1328 1332 O
had 76 79 1333 1336 O
at 80 82 1337 1339 O
least 83 88 1340 1345 O
2 89 90 1346 1347 B-lower_bound
prior 91 96 1348 1353 O
lines 97 102 1354 1359 O
of 103 105 1360 1362 O
therapy 106 113 1363 1370 O
including 114 123 1371 1380 O
one 124 127 1381 1384 O
line 128 132 1385 1389 O
with 133 137 1390 1394 O
chemoimmunotherapy 138 156 1395 1413 B-treatment
including 157 166 1414 1423 I-treatment
an 167 169 1424 1426 I-treatment
anti 170 174 1427 1431 I-treatment
- 174 175 1431 1432 I-treatment
CD20 175 179 1432 1436 I-treatment
monoclonal 180 190 1437 1447 I-treatment
antibody 191 199 1448 1456 I-treatment

Subjects 0 8 1457 1465 O
with 9 13 1466 1470 O
known 14 19 1471 1476 O
HIV 20 23 1477 1480 B-chronic_disease
infection 24 33 1481 1490 I-chronic_disease

Therapeutic 0 11 1491 1502 O
doses 12 17 1503 1508 O
of 18 20 1509 1511 O
corticosteroids 21 36 1512 1527 B-treatment
within 37 43 1528 1534 O
14 44 46 1535 1537 B-upper_bound
days 47 51 1538 1542 I-upper_bound
prior 52 57 1543 1548 I-upper_bound
to 58 60 1549 1551 O
study 61 66 1552 1557 O
entry 67 72 1558 1563 O

Topical 0 7 1564 1571 O
and/or 8 14 1572 1578 O
inhaled 15 22 1579 1586 O
steroids 23 31 1587 1595 B-treatment
are 32 35 1596 1599 O
permitted 36 45 1600 1609 O

Uncontrolled 0 12 1610 1622 O
intercurrent 13 25 1623 1635 B-chronic_disease
illness 26 33 1636 1643 I-chronic_disease
including 34 43 1644 1653 O
, 43 44 1653 1654 O
but 45 48 1655 1658 O
not 49 52 1659 1662 O
limited 53 60 1663 1670 O
to 61 63 1671 1673 O
, 63 64 1673 1674 O
ongoing 65 72 1675 1682 O
or 73 75 1683 1685 O
uncontrolled 76 88 1686 1698 O
systemic 89 97 1699 1707 B-chronic_disease
fungal 98 104 1708 1714 I-chronic_disease
, 104 105 1714 1715 O
bacterial 106 115 1716 1725 B-chronic_disease
, 115 116 1725 1726 O
viral 117 122 1727 1732 B-chronic_disease

absolute 0 8 1733 1741 B-clinical_variable
neutrophil 9 19 1742 1752 I-clinical_variable
count 20 25 1753 1758 I-clinical_variable
≥750 26 30 1759 1763 O
/ 30 31 1763 1764 I-lower_bound
mcL 31 34 1764 1767 I-lower_bound

biologic 0 8 1768 1776 B-treatment
composition 9 20 1777 1788 O
to 21 23 1789 1791 O
blinatumomab 24 36 1792 1804 B-treatment

creatinine 0 10 1805 1815 B-clinical_variable
2.0 11 14 1816 1819 B-lower_bound
X 15 16 1820 1821 I-lower_bound
ULN 17 20 1822 1825 I-lower_bound

defined 0 7 1826 1833 O
as 8 10 1834 1836 O
> 11 12 1837 1838 O
20mg 12 16 1838 1842 B-lower_bound
/ 16 17 1842 1843 I-lower_bound
day 17 20 1843 1846 I-lower_bound
pf 21 23 1847 1849 O
prednisone 24 34 1850 1860 B-treatment
, 34 35 1860 1861 O
or 36 38 1862 1864 O
equivalent 39 49 1865 1875 O

other 0 5 1876 1881 O
infection 6 15 1882 1891 B-chronic_disease
, 15 16 1891 1892 O
symptomatic 17 28 1893 1904 O
congestive 29 39 1905 1915 B-chronic_disease
heart 40 45 1916 1921 I-chronic_disease
failure 46 53 1922 1929 I-chronic_disease
, 53 54 1929 1930 O
unstable 55 63 1931 1939 B-chronic_disease
angina 64 70 1940 1946 I-chronic_disease
pectoris 71 79 1947 1955 I-chronic_disease
, 79 80 1955 1956 O
cardiac 81 88 1957 1964 B-chronic_disease
arrhythmia 89 99 1965 1975 I-chronic_disease

psychiatric 0 11 1976 1987 B-chronic_disease
illness 12 19 1988 1995 I-chronic_disease
/ 19 20 1995 1996 I-chronic_disease
social 20 26 1996 2002 I-chronic_disease
situations 27 37 2003 2013 I-chronic_disease
that 38 42 2014 2018 O
would 43 48 2019 2024 O
limit 49 54 2025 2030 O
compliance 55 65 2031 2041 O
with 66 70 2042 2046 O
study 71 76 2047 2052 O
requirements 77 89 2053 2065 O

radioimmunotherapy 0 18 2066 2084 B-treatment
within 19 25 2085 2091 O
6 26 27 2092 2093 B-upper_bound
weeks 28 33 2094 2099 I-upper_bound
prior 34 39 2100 2105 I-upper_bound
to 40 42 2106 2108 O
entering 43 51 2109 2117 O
the 52 55 2118 2121 O
study 56 61 2122 2127 O

